Nine Chapters Capital Management’s Enzo Biochem, Inc. ENZ Stock Holding History

Nine Chapters Capital Management’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-50,400	Closed	-$422K	–	186
2017 Q1	$422K	Buy	50,400 +19,500	+63%	+$137K	0.57%	59
2016 Q4	$214K	Buy	+30,900	New	+$197K	0.36%	108
2015 Q4	–	Sell	-44,300	Closed	-$140K	–	577
2015 Q3	$140K	Sell	44,300 -51,900	-54%	-$157K	0.01%	882
2015 Q2	$291K	Buy	96,200 +10,200	+12%	+$28.7K	0.02%	727
2015 Q1	$254K	Buy	86,000 +63,700	+286%	+$209K	0.02%	775
2014 Q4	$99K	Sell	22,300 -7,500	-25%	-$35.8K	0.01%	873
2014 Q3	$153K	Buy	+29,800	New	+$159K	0.01%	887

Other funds holding ENZ

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EGA

Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Nine Chapters Capital Management's ENZ Position: Q2 2017 in Review

Nine Chapters Capital Management sold out of Enzo Biochem, Inc. (ENZ) in Q2 2017, closing a stake of 50,400 shares — an estimated $422K sold.

Nine Chapters Capital Management first reported a position in ENZ in Q3 2014 and held it in 7 quarters. The position peaked at $422K in Q1 2017. 120 funds tracked by Wall St. Rank hold ENZ as of Q2 2017.

Nine Chapters Capital Management reported no remaining Enzo Biochem, Inc. position as of Q2 2017 after selling out during the quarter.
Nine Chapters Capital Management sold 50,400 Enzo Biochem, Inc. shares in Q2 2017, an estimated $422K.
Nine Chapters Capital Management first reported a position in Enzo Biochem, Inc. in Q3 2014 and held it in 7 quarters.
Nine Chapters Capital Management's Enzo Biochem, Inc. position peaked at $422K in Q1 2017.
120 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2017.

Based on Nine Chapters Capital Management's 13F filing for Q2 2017, filed 31 Jul 2017.